SEC Form 4 · accession 0000891293-15-000060
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack W Singer
Officer — EVP, Global Medical Affairs · Director
Period of report
Nov 27, 2015
Accepted (ET)
Nov 30, 2015 · 6:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 27, 2015 | S | 2,600 | $1.20 | D | 1,334,250 | D | |
| Common Stock | Nov 27, 2015 | S | 700 | $1.205 | D | 1,333,550 | D | |
| Common Stock | Nov 27, 2015 | S | 7,781 | $1.21 | D | 1,325,769 | D | |
| Common Stock | Nov 27, 2015 | S | 624 | $1.215 | D | 1,325,145 | D | |
| Common Stock | Nov 27, 2015 | S | 3,295 | $1.22 | D | 1,321,850 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to a Rule 10b5-1 trading plan.